Taysha Gene Therapies所有資訊

Taysha Gene Therapies | DEFA14A：其他

04/18 16:27 (美東)

Taysha Gene Therapies | ARS：年度報告

04/18 16:23 (美東)

Taysha Gene Therapies | DEF 14A：股東委託書決議

04/18 16:19 (美東)

Taysha Gene Therapies | S-8：員工福利計劃證券登記

03/19 16:57 (美東)

Taysha Gene Therapies | 8-K：重大事件

03/19 16:22 (美東)

Taysha Gene Therapies | 10-K：年度報表

03/19 16:18 (美東)

Taysha Gene Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(5.6%),VHCP Co-Investment Holdings III, LLC(5.6%)等

02/14 20:48 (美東)

Taysha Gene Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等

02/14 17:31 (美東)

Taysha Gene Therapies | SC 13G：超過5%持股股東披露文件-RTW Investments, LP(9.8%),Roderick Wong, M.D.(9.8%)

02/14 07:11 (美東)

Taysha Gene Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-TCG Crossover GP I, LLC(1.6%),TCG Crossover Fund I, L.P.(1.6%)等

02/09 16:31 (美東)

Taysha Gene Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-FMR LLC(12.002%),Abigail P. Johnson(12.002%)

02/09 09:56 (美東)

Taysha Gene Therapies | 4：持股變動聲明-高管 Alam Kamran

02/06 16:43 (美東)

Taysha Gene Therapies | 8-K：重大事件

01/10 00:00 (美東)

Taysha Gene Therapies | 4：持股變動聲明-高管 Alam Kamran

01/04 00:00 (美東)

Taysha Gene Therapies | 4：持股變動聲明-高管 Nagendran Sukumar

01/04 00:00 (美東)

Taysha Gene Therapies | 4：持股變動聲明-高管 Nolan Sean P.

01/04 00:00 (美東)

Taysha Gene Therapies | 8-K：重大事件

2023/12/20 16:21 (美東)

Taysha Gene Therapies | S-8：員工福利計劃證券登記

2023/12/20 16:20 (美東)

Taysha Gene Therapies | 4：持股變動聲明-首席財務官 Alam Kamran

2023/12/18 16:50 (美東)

Taysha Gene Therapies | 4：持股變動聲明-高管 Nagendran Sukumar

2023/12/18 16:47 (美東)